Jens Schmid

Postdoctoral Fellow
Department of Clinical Pharmacology
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Germany

Biography

Postdoctotal fellow at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart. Done PhD study: “Charakterisierung primärer Tumor-assoziierter Fibroblasten und Tumorzellen aus bronchialen Karzinomen und Untersuchung ihrer Reaktion auf zielgerichtete und zytotoxische Therapie “ at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany (Prof. Dr. W. E. Aulitzky)

Research Intrest

Pharmacogenetics and genomics

List of Publications
Haubeiss S, Schmid JO, Muerdter TE, Sonnenberg M, Friedel G, van der Kuip H, Aulitzky WE.( 2010) Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinoma to a phenotype comparable to that of normal Fibroblasts. Mol Cancer 9: 168
Nagel AC, Schmid J, Auer JS, Preiss A, Maier D. (2010) Constitutively active protein kinase D acts as negative regulator of the Slingshot-phosphatase in Drosophila. Hereditas.147(5)
Schmid JO, Dong M, Haubeiß S, Friedel G, Bode S, Grabner A, Ott G, Mürdter TE, Oren M, Aulitzky WE, van der Kuip H.( 2012) Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin. Cancer Research 72(22): 5824-32

Global Scientific Words in Pharmaceutical Sciences